Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Proton Nuclear Magnetic Resonance Metabonomics Approach for Biomarker Discovery in Nonalcoholic Fatty Liver Disease
Hao Li, Lan Wang, Xianzhong Yan, et al.
Journal of Proteome Research (2011) Vol. 10, Iss. 6, pp. 2797-2806
Closed Access | Times Cited: 69

Showing 26-50 of 69 citing articles:

NMR-based metabonomic study of Chinese medicine Gegen Qinlian Decoction as an effective treatment for type 2 diabetes in rats
Na Tian, Junsong Wang, Pengran Wang, et al.
Metabolomics (2013) Vol. 9, Iss. 6, pp. 1228-1242
Closed Access | Times Cited: 48
Genome-Wide and Experimental Resolution of Relative Translation Elongation Speed at Individual Gene Level in Human Cells
Xinlei Lian, Jiahui Guo, Wei Gu, et al.
PLoS Genetics (2016) Vol. 12, Iss. 2, pp. e1005901-e1005901
Open Access | Times Cited: 46
Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives
Stefano Gitto, Filippo Schepis, Pietro Andreoné, et al.
Metabolites (2018) Vol. 8, Iss. 1, pp. 17-17
Open Access | Times Cited: 39
Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and Applications
Raja Ganesan, Haripriya Gupta, Yoseph Asmelash Gebru, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1160-1160
Open Access | Times Cited: 30
Multichannel Nanogenerator-Driven Collaborative Metabolic Fingerprint Diagnostic Strategy for Early Screening and Risk Evaluation of Nonalcoholic Fatty Liver Disease
Chenjie Yang, Da Zhou, Hailong Yu, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 26, pp. 10841-10850
Closed Access | Times Cited: 3
Changes in human hepatic metabolism in steatosis and cirrhosis
Zoe Schofield, Michelle A.C. Reed, Philip N. Newsome, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 15, pp. 2685-2685
Open Access | Times Cited: 39
Nontargeted urine metabolomics analysis of the protective and therapeutic effects of Citri Reticulatae Chachiensis Pericarpium on high‐fat feed‐induced hyperlipidemia in rats
Wei Zeng, Ke‐Er Huang, Yan Luo, et al.
Biomedical Chromatography (2020) Vol. 34, Iss. 4
Closed Access | Times Cited: 29
Advances in Nutritional Metabolomics
Elizabeth P. Ryan, Adam L. Heuberger, Corey D. Broeckling, et al.
Current Metabolomics (2013) Vol. 1, Iss. 2, pp. 109-120
Open Access | Times Cited: 35
Glutamate–oxaloacetate transaminase activity promotes palmitate lipotoxicity in rat hepatocytes by enhancing anaplerosis and citric acid cycle flux
Robert A. Egnatchik, Alexandra K. Leamy, Sarah A. Sacco, et al.
Journal of Biological Chemistry (2018) Vol. 294, Iss. 9, pp. 3081-3090
Open Access | Times Cited: 31
Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of 1H NMR spectroscopy-based metabonomics and 16S rRNA gene sequencing
Mengjuan Gong, Cai-Yan Zhu, Zhongjie Zou, et al.
Journal of Pharmaceutical and Biomedical Analysis (2021) Vol. 197, pp. 113964-113964
Closed Access | Times Cited: 17
Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies
Ángela Rojas, María del Rosario García-Lozano, Antonio Gil‐Gómez, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 10, Iss. 2, pp. 356-362
Open Access | Times Cited: 11
Blood lactate levels are associated with an increased risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: a real-world study
Yi-Lin Ma, Jiang-Feng Ke, Junwei Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6
Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats
Yu Wang, Jianyun Li, Min Han, et al.
Lipids in Health and Disease (2015) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype
Flavia Noelia Mazzini, Frank Cook, John Gounarides, et al.
Metabolomics (2021) Vol. 17, Iss. 7
Open Access | Times Cited: 15
Cholestatic liver injury model of bile duct ligation and the protection of Huang-Lian-Jie-Du decoction by NMR metabolomic profiling
Dandan Wei, Shanting Liao, Junsong Wang, et al.
RSC Advances (2015) Vol. 5, Iss. 81, pp. 66200-66211
Closed Access | Times Cited: 15
Metabonomic analysis of liver tissue from BALB/c mice with d-galactosamine/lipopolysaccharide-induced acute hepatic failure
Bo Feng, Shengming Wu, Feng Liu, et al.
BMC Gastroenterology (2013) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Transcriptomics and Metabolomics for Co-Exposure to a Cocktail of Neonicotinoids and the Synergist Piperonyl Butoxide
Liwei Xu, Xinxin Xu, Hua Kuang, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 5, pp. 3108-3118
Closed Access | Times Cited: 4
Metabolomics-based search for therapeutic agents for non-alcoholic steatohepatitis
Yoshihiko Terashima, Shin Nishiumi, Akihiro Minami, et al.
Archives of Biochemistry and Biophysics (2014) Vol. 555-556, pp. 55-65
Open Access | Times Cited: 12
Metabonomic window into hepatitis B virus-related hepatic diseases
Qiang Hou
World Journal of Hepatology (2016) Vol. 8, Iss. 1, pp. 1-1
Open Access | Times Cited: 12
Analysis of Therapeutic Effect ofIlex hainanensisMerr. Extract on Nonalcoholic Fatty Liver Disease through Urine Metabolite Profiling by Ultraperformance Liquid Chromatography/Quadrupole Time of Flight Mass Spectrometry
Jingjing Li, Jie Yang, Wei‐xi Cui, et al.
Evidence-based Complementary and Alternative Medicine (2013) Vol. 2013, pp. 1-12
Open Access | Times Cited: 12
Theory and Applications of NMR-Based Metabolomics in Human Disease Diagnosis
Abdul‐Hamid Emwas, Jasmeen S. Merzaban, Haçène Serrai
BENTHAM SCIENCE PUBLISHERS eBooks (2015), pp. 93-130
Closed Access | Times Cited: 7
Early detection of metabolic changes in drug-induced steatosis using metabolomics approaches
Helena Yong, Gérald Larrouy-Maumus, Mire Zloh, et al.
RSC Advances (2020) Vol. 10, Iss. 67, pp. 41047-41057
Open Access | Times Cited: 6
Impaired Ca2+ signaling due to hepatic steatosis mediates hepatic insulin resistance in Alström syndrome mice that is reversed by GLP-1 analog treatment
Eunüs S. Ali, Dorothée Girard, Nikolai Petrovsky
AJP Cell Physiology (2021) Vol. 321, Iss. 1, pp. C187-C198
Closed Access | Times Cited: 6
TM6SF2/PNPLA3/MBOAT7 loss-of-function genetic variants impact on NAFLD development and progression both in patients and inin vitromodels
Miriam Longo, Marica Meroni, Veronica Erconi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 5
Identification of Plasmatic Biomarkers of Foie Gras Qualities in Duck by Metabolomics
Zohre Mozduri, Nathalie Marty-Gasset, Bara Lo, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 5

Scroll to top